You are not logged in so some information on this page has been withheld. To see more, please log in or sign up.
2026 › March › 29
Psychedelic
4 months ago
This biopharma play with two key drugs for treatment-resistant depression could see its stock rise by more than 230%, according to a Deutsche Bank analyst.
page 1 of 1